JPM23: Vaccine developers as dealmakers, Gilead’s trial tea leaves and building platform companies
Bio Pharma Dive
JANUARY 10, 2023
Moderna’s Stéphane Bancel and Pfizer’s Albert Bourla hinted Monday at greater dealmaking to come for their companies, while Gilead gave investors an update on an important cancer drug trial.
Let's personalize your content